← Back to Clinical Trials
Recruiting NCT07064967

NCT07064967 Non-Helium Magnetoencephalography in Autism Spectrum Disorder

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07064967
Status Recruiting
Phase
Sponsor Guangzhou Women and Children's Medical Center
Condition Autism Spectrum Disorder (ASD)
Study Type OBSERVATIONAL
Enrollment 80 participants
Start Date 2024-11-05
Primary Completion 2027-12-31

Trial Parameters

Condition Autism Spectrum Disorder (ASD)
Sponsor Guangzhou Women and Children's Medical Center
Study Type OBSERVATIONAL
Phase N/A
Enrollment 80
Sex MALE
Min Age 6 Years
Max Age 12 Years
Start Date 2024-11-05
Completion 2027-12-31
Interventions
Magnetoencephalography

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this observational study is to learn how brain activity in children with autism spectrum disorder (ASD) differs from typical developing children using magnetoencephalography (MEG). The main questions this study aims to answer are: Do children with ASD show different patterns of neural oscillation compared to typically developing children? Can MEG identify specific brain features that help ASD diagnosis? Participants will undergo MEG scan in both resting and tasking state, and their brain activity will be analyzed for characteristic neural oscillations and connectivity patterns. This study may help develop better tools for early ASD diagnosis.

Eligibility Criteria

Inclusion Criteria: * Boys aged 6 to 12 years; * Diagnosis of Autism Spectrum Disorder meeting DSM-5 criteria; * Intelligence quotient (IQ) score \> 70 (assessed via Wechsler Intelligence Scale for Children or other validated cognitive test); * Sufficient compliance to participate in MEG experiments. Exclusion Criteria: * Comorbid neurological disorders, genetic syndromes, or severe developmental disabilities; * Metallic implants that may interfere with MEG signal acquisition; * Current use of antipsychotic medications or sedatives.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology